Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun 10:4:69.
doi: 10.3389/fneur.2013.00069. eCollection 2013.

Hemorrhagic transformation: a review of the rate of hemorrhage in the major clinical trials of acute ischemic stroke

Eric S Sussman  1 , E Sander Connolly Jr
Affiliations

Hemorrhagic transformation: a review of the rate of hemorrhage in the major clinical trials of acute ischemic stroke

Eric S Sussman et al. Front Neurol. .

Abstract

Acute ischemic stroke is a devastating disease that is often complicated by hemorrhagic transformation. While significant advances have been made over the past two decades with regard to emergent treatment of AIS, many of the therapeutic options are limited by an increased risk of hemorrhage. Here, we sought to review the rates of hemorrhagic transformation in the major clinical trials of AIS intervention. Since the reviewed clinical trials vary significantly in terms of study design, eligibility criteria, stroke severity, and baseline demographic data, direct comparisons between the various trials is not valid. Nevertheless, this review is intended to consolidate the pertinent data on hemorrhagic transformation in order to call attention to any patterns that may warrant further investigation.

Keywords: acute ischemic stroke; fibrinolysis; hemorrhagic transformation; intracerebral hemorrhage; mechanical thrombectomy.

PubMed Disclaimer

References

    1. Ariesen M. J., Claus S. P., Rinkel G. J. E., Algra A. (2003). Risk factors for intracerebral hemorrhage in the general population. Stroke 34, 2060–206510.1161/01.STR.0000080678.09344.8D - DOI - PubMed
    1. Broderick J., Connolly S., Feldmann E., Hanley D., Kase C., Krieger D., et al. (2007). Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, high blood pressure research council, and the quality of care and outcomes in research interdisciplinary working group. Stroke 38, 2001–202310.1161/STROKEAHA.107.183689 - DOI - PubMed
    1. Broderick J. P., Palesch Y. Y., Demchuk A. M., Yeatts S. D., Khatri P., Hill M. D., et al. (2013). Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N. Engl. J. Med. 368, 893–90310.1056/NEJMoa1214300 - DOI - PMC - PubMed
    1. Castaño C., Dorado L., Guerrero C., Millán M., Gomis M., Perez de la Ossa N., et al. (2010). Mechanical thrombectomy with the solitaire AB device in large artery occlusions of the anterior circulation: a pilot study. Stroke 41, 1836–184010.1161/STROKEAHA.110.584904 - DOI - PubMed
    1. Clark W. M., Wissman S., Albers G. W., Jhamandas J. H., Madden K. P., Hamilton S. (1999). Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: a randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA 282, 2019–202610.1001/jama.282.21.2019 - DOI - PubMed

LinkOut - more resources